Meredith Hay

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Cognitive Impairment

Walled Carbon Nanotubes

Cerebral Ischemia

Top Venues

The Journal of pharmacology and experimental therapeutics

Current hypertension reports

This page only lists publications with an associated author ORCID identifier.

Publications

David Encinas-Basurto, John P Konhilas, Robin Polt, Meredith Hay, Heidi M Mansour
Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release. Pharmaceutics 14 (3) (2022)
Meredith Hay, Carol Barnes, Matt Huentelman, Roberta Brinton, Lee Ryan
Hypertension and Age-Related Cognitive Impairment: Common Risk Factors and a Role for Precision Aging. Current hypertension reports 22 (10) (2020)
Meredith Hay, Robin Polt, Michael L Heien, Todd W Vanderah, Tally M Largent-Milnes, Kathleen Rodgers, Torsten Falk, Mitchell J Bartlett, Kristian P Doyle, John P Konhilas
A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction. The Journal of pharmacology and experimental therapeutics 369 (1) (2019)